Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
Title:
Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
Author:
Desai, Akshay S. Lewis, Eldrin F. Li, Rebecca Solomon, Scott D. Assmann, Susan F. Boineau, Robin Clausell, Nadine Diaz, Rafael Fleg, Jerome L. Gordeev, Ivan McKinlay, Sonja O'Meara, Eileen Shaburishvili, Tamaz Pitt, Bertram Pfeffer, Marc A.
Appeared in:
American heart journal
Paging:
Volume 162 (2011) nr. 6 pages 9.719999999035E12 p.